The Next Generation of Cardiopulmonary Care
NuvoAir is a virtual-first specialty care provider that empowers and engages people living with complex heart and lung conditions like COPD, Congestive Heart Failure (CHF), and Asthma around the world.
Managing patients with COPD and CHF is complex and challenging
Cardiopulmonary patients, many of whom are struggling with multiple comorbidities, are often isolated, disengaged, and ignored by the healthcare system. Worse yet, point solutions have failed to deliver meaningful outcomes.
One in two seniors has heart or lung complications
Exacerbations drive 60% of hospital admissions
70% of COPD admissions are associated with comorbidities
Wait times are 4 to 16 weeks to see a cardiologist or pulmonologist
NuvoAir embraces the complexity of cardiopulmonary conditions
NuvoAir’s virtual-first care model helps prevent exacerbations associated with COPD and CHF by integrating a virtual clinic, personalized care, connected monitoring devices, and an omnichannel engagement engine to break the cycle of disconnection and failure.
Reimagining heart and lung care
Personalized programs
We tailor clinical programs to members' unique needs, based on their motivations and risk factors.
Smoking cessation Pulmonary and cardiac rehabilitation Fitness, diet, and nutrition Treatment plan review
Clinically relevant data
Our devices continuously and remotely collect biomarkers to empower the best clinical decisions.
Oxygen saturation Activity Spirometry Weight Medication Adherence Blood pressure Cough Heart rateVirtual clinic
Our interdisciplinary care team conducts timely clinical interventions whenever patients need help or signals in the data indicate concern.
Cardiologists and Pulmonologists Nurses Respiratory therapists Health coaches
Exacerbation prevention
Our analytics engine drives the next best action in our clinical model to predict and prevent exacerbations.
Reduced healthcare costs Better clinical outcomes Improved patient experience Enhanced Hedis/Stars/CAHPS measuresProven Results
Our virtual-first care solution effectively engages and manages people with COPD and comorbidities.
80% Decrease in hospitalizations 60% Decrease in exacerbations 87% Improved quality of life NPS 60 Net promoter score *Based on patient reported outcomes from a 2021-2022 pilot with rural patients at a primary care clinic in Kentucky and a pulmonary specialty clinic in Indiana.
Partnering across the spectrum of care
In network and providing care across 15+ US states
Learn more about how NuvoAir can support your cardiopulmonary care needs
Our team will reach out to share more information about our virtual-first specialty care model.
